Heterogeneity of PIK3CA mutational status at the single cell level in circulating tumor cells from metastatic breast cancer patients
about
Tumor Heterogeneity, Single-Cell Sequencing, and Drug ResistanceEvaluation and consequences of heterogeneity in the circulating tumor cell compartmentCirculating tumor cells in breast cancerTreatment Algorithms Based on Tumor Molecular Profiling: The Essence of Precision Medicine TrialsTumour Heterogeneity: The Key Advantages of Single-Cell AnalysisDissecting the Heterogeneity of Circulating Tumor Cells in Metastatic Breast Cancer: Going Far Beyond the Needle in the HaystackAccurate prediction of response to endocrine therapy in breast cancer patients: current and future biomarkersEndocrine therapy considerations in postmenopausal patients with hormone receptor positive, human epidermal growth factor receptor type 2 negative advanced breast cancersCirculating Tumor Cells Versus Circulating Tumor DNA in Colorectal Cancer: Pros and Cons.Microfluidic Sample Preparation for Single Cell Analysis.Single-cell sequencing and tumorigenesis: improved understanding of tumor evolution and metastasis.Evaluation of a novel approach to circulating tumor cell isolation for cancer gene panel analysis in patients with breast cancer.EGFR-Based Immunoisolation as a Recovery Target for Low-EpCAM CTC Subpopulation.KRAS mutation analysis of single circulating tumor cells from patients with metastatic colorectal cancerPrognostic Impact of Modulators of G proteins in Circulating Tumor Cells from Patients with Metastatic Colorectal Cancer.Sensitive cytometry based system for enumeration, capture and analysis of gene mutations of circulating tumor cellsThe potential for liquid biopsies in the precision medical treatment of breast cancer.Single circulating tumor cell sequencing as an advanced tool in cancer management.Single-cell analysis of CTCs with diagnostic precision: opportunities and challenges for personalized medicine.Challenges for CTC-based liquid biopsies: low CTC frequency and diagnostic leukapheresis as a potential solution.The Role of BEAMing and Digital PCR for Multiplexed Analysis in Molecular Oncology in the Era of Next-Generation Sequencing.Cell-free DNA as a molecular tool for monitoring disease progression and response to therapy in breast cancer patients.Mutation distributions and clinical correlations of PIK3CA gene mutations in breast cancer.Liquid Biopsy and its Potential for Management of Hepatocellular Carcinoma.Feasibility of a workflow for the molecular characterization of single cells by next generation sequencingThe promise of circulating tumor cells for precision cancer therapy.Circulating tumor cells: clinical validity and utility.Characterization of single circulating tumor cells.Phenotypic Heterogeneity of Circulating Tumor Cells Informs Clinical Decisions between AR Signaling Inhibitors and Taxanes in Metastatic Prostate Cancer.Mutational analysis of single circulating tumor cells by next generation sequencing in metastatic breast cancer.A Novel Workflow to Enrich and Isolate Patient-Matched EpCAMhigh and EpCAMlow/negative CTCs Enables the Comparative Characterization of the PIK3CA Status in Metastatic Breast Cancer.Frequent detection of PIK3CA mutations in single circulating tumor cells of patients suffering from HER2-negative metastatic breast cancer.Androgen receptor expression on circulating tumor cells in metastatic breast cancer.A conduit to metastasis: circulating tumor cell biology.Tumor Heterogeneity in Breast Cancer.Comprehensive mutation and copy number profiling in archived circulating breast cancer tumor cells documents heterogeneous resistance mechanisms.Application of single-cell sequencing in human cancer.Hyaluronic acid-functionalized electrospun PLGA nanofibers embedded in a microfluidic chip for cancer cell capture and culture.Liquid Biopsy in Clinical Management of Breast, Lung, and Colorectal Cancer.Circulating Tumor Cells: Markers and Methodologies for Enrichment and Detection.
P2860
Q26744341-E56AD781-8BD8-47EE-9A03-D93B904B89DCQ26765357-A6B3B270-B139-4772-99FD-F393E150AD6CQ26774808-A9CEAFCD-B404-4758-A227-8912F359B612Q26776394-756EA422-1254-47CC-B1F5-550335A48AF4Q28066914-4B4E7D2F-0EA6-469C-834A-D25BDFFF10ACQ28067549-FB4549B5-3A15-4D91-B4A2-76F2A2FF7066Q28069856-CAC26F8A-55C9-4E2C-BC82-19561D60510DQ28081872-730E5AEF-AB24-473F-A339-F56B06EF44F8Q30355079-C409975D-0114-4FFC-84E6-172BC4D2575DQ30366102-417375CD-6FBA-43A2-BC0C-BAF54571D580Q33559128-1BB96853-5618-42CB-9660-5E69ACFAE10CQ33684887-6577C84B-1EA3-4E62-9DA3-F3626410F013Q36155201-526887C5-FF84-46A4-AA1B-6E1D8D47F7C5Q36362489-50CCEEA1-875E-4994-BC4B-CC0D884F299EQ36621729-8A4FA618-6BA1-440D-A42F-8D0C3B582981Q36746316-2CC0CD28-D3B3-4FE2-B145-F069BCB03073Q36849660-DC8FC936-4F11-4BAF-B61C-5BD798095C66Q38631119-C12FB640-7F03-43B0-AB6F-6A5B69AE2C05Q38633382-3182EA47-91D7-44B4-8778-28C7F9037274Q38639962-37C350A8-E5FB-4C5A-A979-360690E95356Q38664177-7A9E0642-72CC-4370-82A1-052AC2AD6A82Q38669236-391C6162-6F91-4A62-B82B-B08011E5DD3EQ38752466-144335B6-5E9A-4F6E-8D44-9E57A20AECD1Q38770935-02DA3389-B877-4848-8C90-CED1A3275223Q38778349-86DDD3D3-5CC9-4B2A-995A-A23630363341Q39031157-820513EC-927C-4159-8954-26E8BE195D58Q39151285-59085ED7-7878-4888-B3AB-0036D13CEA08Q39275082-EEAFE5FE-3319-41C3-A25E-8CD639F34ED2Q40496979-C87BB7A8-573D-481F-A9B2-F05A4ADF0A13Q41225190-85701BA5-3D45-4A64-A092-EEAB05C6D0F3Q41661081-6632F782-FB37-447D-B5E2-D47E2662F9CFQ41763224-4091C8DF-7F7A-4CBC-BFD6-2DDDD2E51FFBQ42366191-2BC9D8BB-C3C6-419C-BD18-0A5A5285566CQ46280012-646FFD4E-7DCB-44D5-8273-A35C43D28C0FQ47146956-2234A122-39A7-4136-BB0A-2AA831631F69Q47682423-96AF9E5D-970C-429F-AADE-87EFD602BA21Q47857737-CAB699E7-848F-4FBF-A6B9-678A3790AED2Q48168153-01B94435-1765-4D7F-9AC5-1FA140A3C913Q49740946-CED8BF54-4C7A-4AE8-9A79-52E0397C514CQ50199981-AB0E97EF-8491-4323-8C40-C7E87F7C8B2C
P2860
Heterogeneity of PIK3CA mutational status at the single cell level in circulating tumor cells from metastatic breast cancer patients
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Heterogeneity of PIK3CA mutati ...... astatic breast cancer patients
@en
type
label
Heterogeneity of PIK3CA mutati ...... astatic breast cancer patients
@en
prefLabel
Heterogeneity of PIK3CA mutati ...... astatic breast cancer patients
@en
P2093
P2860
P50
P1433
P1476
Heterogeneity of PIK3CA mutati ...... astatic breast cancer patients
@en
P2093
Francesca Galardi
Marta Pestrin
Natalie Turner
Pamela Pinzani
P2860
P304
P356
10.1016/J.MOLONC.2014.12.001
P577
2014-12-09T00:00:00Z